Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Hu8F4 in Patients With Advanced Hematologic Malignancies

NCT02530034 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02530034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02530034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Hu8F4 in Patients With Advanced Hematologic Malignancies
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
January 31, 2019
Completion date
January 1, 2027
Enrollment
72 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia arising from previous myelodysplastic syndrome, blast phase chronic myelogenous leukemia, bcr-abl1 positive, hematopoietic and lymphoid cell neoplasm, high risk myelodysplastic syndrome, myelodysplastic syndrome with excess blasts-1, myelodysplastic syndrome with excess blasts-2, myelofibrosis, recurrent acute myeloid leukemia, recurrent chronic myelomonocytic leukemia, refractory chronic myelomonocytic leukemia, secondary acute myeloid leukemia